Pacific Biosciences Q3 Results Expected November 4
Pacific Biosciences is expected to report Q3'26 results after the market closes on November 4. EPS is estimated at $(0.13).
Related stories
Optimus SBR Acquires Greenlight Consulting to Expand AI and Automation Capabilities
The acquisition is intended to expand capabilities for financial institutions, public sector organizations and healthcare.
M impact | EQUITY | Nov 03, 2026, 03:30 PM UTC
Oracle Said To Allocate 65% Of USD 10B Stock Sale To 10 Investors
L impact | EQUITY | Nov 03, 2026, 03:29 PM UTC
Mexico’s Main Stock Index Extends Gains Above 2%
M impact | EQUITY | Nov 03, 2026, 03:28 PM UTC
Sportradar Group Reports Third-Quarter Revenue of EUR362.5M
M impact | EQUITY | Nov 03, 2026, 03:28 PM UTC
BBVA Places CHF 290 Million Green Bond
BBVA placed CHF 290 million in a two-tranche senior preferred green bond issuance.
L impact | EQUITY | Nov 03, 2026, 03:28 PM UTC
NexPoint Residential Trust Reports Quarterly Results
NexPoint Residential Trust reported results for the quarter ended September 30.
M impact | EQUITY | Nov 03, 2026, 03:27 PM UTC